XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Condensed Consolidated Statements of Operations        
PEDMARK product sales, net $ 12,462 $ 6,974 $ 30,865 $ 21,655
Licensing revenue       17,958
Total revenues 12,462 6,974 30,865 39,613
Operating expenses:        
Cost of product sales 660 1,357 2,000 2,515
Research and development 29 97 230 257
Selling and marketing 5,210 4,601 12,510 14,482
General and administrative 6,752 6,121 19,853 18,857
Total operating expenses (12,651) (12,176) (34,593) (36,111)
(Loss)/Income from operations (189) (5,202) (3,728) 3,502
Other (expense)/income        
Unrealized foreign exchange gain/(loss) (3)   27 (55)
Amortization expense (12) (21) (38) (64)
Unrealized loss on securities   (3) (2) (14)
Interest income 152 516 559 1,283
Interest expense (586) (1,025) (1,772) (3,103)
Total other expense (449) (533) (1,226) (1,953)
Net (loss)/income $ (638) $ (5,735) $ (4,954) $ 1,549
Basic net (loss)/income per common share $ (0.02) $ (0.21) $ (0.18) $ 0.06
Diluted net (loss)/income per common share $ (0.02) $ (0.21) $ (0.18) $ 0.06
Weighted-average number of common shares outstanding basic 27,889 27,371 27,711 27,371
Weighted-average number of common shares outstanding diluted 27,889 27,371 27,711 28,015